يعرض 1 - 20 نتائج من 76 نتيجة بحث عن '"Síndrome de Miller Fisher"', وقت الاستعلام: 0.82s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal

    المصدر: Revista 16 de Abril; Vol. 62 (2023): publicación continua; e1675 ; 1729-6935

    وصف الملف: application/pdf

    Relation: https://rev16deabril.sld.cu/index.php/16_04/article/view/1675/904; https://rev16deabril.sld.cu/index.php/16_04/article/view/1675/918; Espitia-Segura O, Penagos N, Hernández-Sarmiento R. Parálisis Facial Secundaria A Arteritis De La Arteria Carótida Interna En Paciente Escolar. Rev Ecuat Neurol [Internet]. 2019 [citado 05/07/2022]; 28(3):94-97. Disponible en: http://scielo.senescyt.gob.ec/scielo.php?script=sci_arttext&pid=S2631-25812019000300094&lng=es; Celi Celi JM, Yusta Izquierdo A, Sánchez Herán I. Protocolo diagnóstico de la afectación del nervio facial. Medicine [Internet]. 2019 [citado 05/07/2022]; 12(77):4576-81. Disponible en: http://www.residenciamflapaz.com/Articulos%20Residencia%2017/337%20Dx%20afectacion%20nervio%20facial.pdf; Muñoz-Lombo JP, Quintero-González DC, Cárdenas-Prieto JM, Casanova-Valderrama ME. Diplejía facial como manifestación de neuroleptospirosis. Acta Médica Colombiana [Internet]. 2021 [citado 03/07/2022]; 46(2):1-4. DOI:10.36104/amc.2021.1947; Piñol Pipoll G, Larrodé Pellicer P, de la Puerta González-Miró I, Tejero Juste C, Iñiguez Martínez C, Santos Lasaosa S, et al. Diplejia facial: variante regional del síndrome de Guillian-Barré. An Med Interna [Internet]. 2007 [citado 03/02/2020]; 24(1):24-26. Disponible en: https://scielo.isciii.es/pdf/ami/v24n1/nota1.pdf; Ojeda-Manzano A, Pérez-Padilla EA, Salgado-Burgos H. Tratamiento de la parálisis facial periférica bilateral. A propósito de un caso. Cienc Humanismo En Salud [Internet]. 2019 [citado 07/03/2020]; 6(3):78-83. Disponible en: http://revista.medicina.uady.mx/revista/index.php/cienciayhumanismo/article/view/142; Erro ME, Urriza J, Gila L, Orbara E, de Gurtubay IG. Parálisis facial bilateral secundaria a infección por virus de Epstein-Barr. An Sist Sanit Navar [Internet]. 2010 [citado 12/12/2019]; 33(1):107-12. Disponible en: https://scielo.isciii.es/pdf/asisna/v33n1/nota3.pdf; Vargas J, Niebles C. Diplejia facial. Una variante del síndrome de Guillain-Barré. Revista Med [Internet]. 2015 [citado 03/02/2020]; 23(2):110-3. Disponible en: https://www.redalyc.org/pdf/910/91044134012.pdf; Pothiawala S, Lateef F. Bilateral Facial Nerve Palsy: A Diagnostic Dilemma. Case Rep Emerg Med [Internet]. 2012 [citado 13/12/2019]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/23326715/; Serrano-Cajo IE, Vallejos C, Luis Ángel. Características clínico epidemiológicas del Síndrome De Guillain Barré en pacientes atendidos en el Hospital Nacional Almanzor Aguinaga Asenjo 2012 – 2018 [tesis]. Chiclayo-Perú: Universidad de San Martín de Porres; 2020. Disponible en: https://repositorio.usmp.edu.pe/bitstream/handle/20.500.12727/6019/chunga_vie.pdf?sequence=1&isAllowed=y; Lupiáñez-Seoanea P, Santamaría-Marín A, Monroy-Gómez C. Parálisis facial bilateral. Presentación atípica de un Síndrome de Guillain-Barré. Rev Clínica Med Fam [Internet]. 2018 [citado 07/03/2020]; 11(2):105-106. Disponible en: https://scielo.isciii.es/pdf/albacete/v11n2/1699-695X-albacete-11-02-00105.pdf; Hoffmann-Rigo D de F, Ross C, Hofstätter LM, Azevedo Pompilio-Leonel Ferreira MF. Guillain Barré syndrome: epidemiological clinical profile and nursing care. EG [Internet]. 2020 [citado 07/03/2020]; 19(1):376-389. Disponible en: https://scielo.isciii.es/pdf/eg/v19n57/en_1695-6141-eg-19-57-346.pdf; Milian E, Anzules J, Veliz I, Betancourt L. Diplejía Facial Periférica Bilateral como debut del Síndrome de Guillain Barré. Mediciencias UTA [Internet]. 2019 [citado 07/03/2020]; 3(2):10-3. Disponible en: https://revistas.uta.edu.ec/erevista/index.php/medi/article/download/1320/1319; Lowe J, Pfaff J. The Ultimate Poker Face: A Case Report of Facial Diplegia, a Guillain-Barré Variant. Clin Pract Cases in Emerg Med [Internet]. 2020 [citado 19/03/2021]; 4(2):150-3. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220008/; Palomino Granados L, Herrera Ortiz AF, Rincón Cuenca NT. Síndrome de Miller Fisher: Reporte de Caso y descripción de la enfermedad. Revista Cuarzo [Internet]. 2020 [citado 18/03/2021]; 26(1):36-40. Disponible en: https://revistas.juanncorpas.edu.co/index.php/cuarzo/article/view/477/441; Carpio-Orantes LD, Peniche-Moguel KG, Sánchez-Díaz JS, Pola-Ramírez MR, Perfecto-Arroyo MA, Solís-Sánchez I, et al. Síndrome de Guillain-Barré durante el brote de Zika en Veracruz, México, en 2016-2017. Med Int Méx [Internet]. 2020 [citado 07/03/2020]; 36(1):33-9. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2020/mim201e.pdf; Serrano P, Hernández N, Arroyo JA, de Llobet JM, Domingo P. Bilateral Bell Palsy and Acute HIV Type 1 Infection: Report of 2 Cases and Review. CID [Internet]. 2007 [citado 18/03/2021]; 44(6):e57-e61. Disponible en: https://academic.oup.com/cid/article/44/6/e57/365125; Hernández K, Múnera M. Síndromes neurológicos paraneoplásicos. Archivos de Alergia e Inmunología Clínica [Internet]. 2021 [citado 31/05/2022]; 52(3):109-115. Disponible en: http://adm.meducatium.com.ar/contenido/articulos/28201090115_2133/pdf/28201090115.pdf; Higes Pascual F, Carvalho Monteiro G, Sánchez Herán I, Povedano Margarit B, Yusta Izquierdo A. Síndromes paraneoplásicos del sistema nervioso. Medicine [Internet]. 2019 [citado 31/05/2022]; 12(78):4616-29. DOI:10.1016/j.med.2019.05.013; Morales-Ramírez F, Bertado-Cortés B, Carrera-Pineda R. Vasculitis Primaria del Sistema Nervioso Central Tratada Exitosamente con Rituximab: Reporte de Caso. Rev Mex Neurocien [Internet]. 2018 [citado 25/09/2020]; 19(3):85-94. Disponible en: https://www.medigraphic.com/pdfs/revmexneu/rmn-2018/rmn183i.pdf; Graña D, Castro L, Cichesky V, Cancela M. Vasculitis Primaria del Sistema Nervioso Central: Presentación de caso Clínico. Anfamed [Internet]. 2018 [citado 25/09/2020]; 5(1):104-117. Disponible en: http://www.scielo.edu.uy/scielo.php?pid=S2301-12542018000100104&script=sci_arttext&tlng=pt; https://rev16deabril.sld.cu/index.php/16_04/article/view/1675

  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal

    المصدر: Revista Cubana de Neurologia y Neurocirugia; Vol. 11, No. 2 (2021): mayo-agosto ; Revista Cubana de Neurología y Neurocirugía; Vol. 11, No. 2 (2021): mayo-agosto ; 2225-4676

    جغرافية الموضوع: Neurología, Neurociencias

    وصف الملف: application/pdf

    Relation: https://revneuro.sld.cu/index.php/neu/article/view/446/632; https://revneuro.sld.cu/index.php/neu/article/downloadSuppFile/446/284; https://revneuro.sld.cu/index.php/neu/article/downloadSuppFile/446/285; Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barré syndrome. Lancet. 2016;388:717-27.; Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. Neuro epidemiology. 2011;36:123-33.; Dimachkie MM, Barohn RJ. Guillain-Barre Syndrome and Variants. Neurol Clin. 2013;31(2):491-510. Doi:10.1016/j.ncl.2013.01.005.; Instituto Mexicano del Seguro Social. Dirección de Prestaciones Médicas. Diagnóstico y Tratamiento del Síndrome de Guillain Barré en el Segundo y Tercer nivel de Atención. Guía de práctica clínica. Ciudad de México: Instituto Mexicano del Seguro Social; 2016 [citado: 21/11/2020]. Disponible en: http://www.imss.gob.mx/sites/all/statics/guiasclinicas/089GRR.pdf; Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, et al. Diagnosis and management of Guillain-Barré syndrome in ten steps. Evidence-based guidelines. Nat Rev Neurol. 2019;15:271-83.; Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol. 1998 Nov;44(5):780-8. Doi:10.1002/ana.410440512.; Yoon B-A, Bae JS, Kim JK. Electrognostic findings of Guillain-Barré syndrome. Ann Clin Neurophysiol. 2020;22(1):13-8. Doi:10.14253/acn.2020.22.1.13; Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998 Oct;51(4):1110-5. Doi:10.1212/wnl.51.4.1110; Hao Y, Wang W, Jacobs BC, Qiao B, Chen M, Liu D, et al. Antecedent infections in Guillain-Barré syndrome: a single-center, prospective study. Ann Clin Transl Neurol. 2019 Dec;6(12):2510-7. Doi:10.1002/acn3.50946; Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016 Apr 9;387(10027):1531-9. Doi:10.1016/S0140-6736(16)00562-6; Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690. Doi:10.1001/jamaneurol.2020.1127; Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-41. Doi:10.1016/j.ijsu.2010.02.007.; Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic Reviews. 2015;4:1. Disponible en: http://www.systematicreviewsjournal.com/content/4/1/1; Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008 Apr 26;336(7650):924-6. Doi:10.1136/bmj.39489.470347.AD.; Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011 Apr;64(4):401-6. Doi:10.1016/j.jclinepi.2010.07.015.; Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, et al. Brighton Collaboration GBS Working Group. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011 Jan 10;29(3):599-612. Doi:10.1016/j.vaccine.2010.06.003.; Rajabally YA, Durand MC, Mitchell J, Orlikowski D, Nicolas G. Electrophysiological diagnosis of Guillain-Barre syndrome subtype: could a single study suffice? J Neurol Neurosurg Psychiatry. 2015;86:115-9. Doi:10.1136/jnnp-2014-307815; Coen M, Jeanson G, Culebras Almeida A, Hubers A, Stierlin F, Najjar I, et al. Guillain-Barré syndrome as a complication of SARS-CoV-2 infection. Brain, Behavior and Immunity. 2020;87:111-2. Doi:10.1016/j.bbi.2020.04.074; Sedaghat Z, Kirimi N. Guillain Barre syndrome associated with COVID-19 infection: A case report. Journal of Clinical Neuroscience. 2020;76:233-5. Doi:10.1016/j.jocn.2020.04.062; Agosti E, Giorgianni A, D’Amore F, Vanacci G, Balbi S, Locatelli D. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review. Neurolog Scienc. 2020;42(11):1- 6. Doi:10.1007/s10072-020-04553-9; Arnaud S, Budowski C, Ng Wing Tin S, Degos B. Post SARS-CoV-2 Guillain-Barré syndrome. Clin Neurophysiol. 2020 Jul;131(7):1652-1654. doi:10.1016/j.clinph.2020.05.003.; Tiet MY, AlShaikh N. Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK. BMJ Case Rep. 2020;13:e236536. Doi:10.1136/bcr-2020-236536; Sancho-Saldana A, Lambea Gil A, Capablo Liesa JL, Barrera Caballo MR, Haddad Garay M, Rivero Celada D, et al. Guillain–Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection. Clin Medicine. 2020;20(4):e93-94. Doi:10.7861/clinmed.2020-0213; Guijarro-Castro C, Rosón-González M, Abreu A, García-Arratibel A, Ochoa-Mulas M. Síndrome de Guillain-Barré tras infección por SARS-CoV-2. Comentarios tras la publicación de 16 nuevos casos. Neurología. 2020;35(6):412-5. Doi:10.1016/j.nrl.2020.06.002; Zito A, Alfonsi E, Franciotta D, Todisco M, Gastaldi M, Cotta Ramusino M, et al. COVID-19 and Guillain–Barré Syndrome: A Case Report and Review of Literature. Front Neurol. 2020;11:909. Doi:10.3389/fneur.2020.00909; Korem S, Gandhi H, Dayag DB. Guillain-Barré syndrome associated with COVID-19 disease. BMJ Case Rep. 2020;13:e237215. Doi:10.1136/bcr-2020-237215; Paybast S, Gorji R, Mavandadi S. Guillain-Barré Syndrome as a Neurological Complication of Novel COVID-19 Infection. A Case Report and Review of the Literature. The Neurologist. 2020;25:101-3.; Khalifa M, Zakaria F, Ragab Y, Saad A, Bamaga A, Emad Y, et al. Guillain-Barré Syndrome Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Detection and Coronavirus Disease 2019 in a Child. J Ped Infect Dis Soc. 2020;9(4):510-3. Doi:10.1093/jpids/piaa086; Michiles Frank CHM, Rocha Almeida TV, Almeida Marques E, Sousa Monteiro Q, Silveira Feitoza V, Silva Borba MG, et al. Guillain-Barre´ Syndrome Associated with SARS-CoV-2 Infection in a Pediatric Patient. J Trop Pediatr. 2020;fmaa044. Doi:10.1093/tropej/fmaa044; Hutchins KL, Jansen JH, Comer AD, Scheer RV, Zahn GS, Capps AE, et al. COVID-19-Associated Bifacial Weakness with Paresthesia Subtype of Guillain-Barré Syndrome. Am J Neuroradiol. 2020;41(9):1707-11. Doi:10.3174/ajnr.A6654; Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020;382(26):2574-6. Doi:10.1056/NEJMc2009191.; Frazi MA, Ayromlou H, Jahanbakhsh N, Bavil PH, Janzadeh A, Shayan FK. Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report. Journal of Neuroimmunology. 2020;346:577294. Doi. 10.1016/j.jneuroim.2020.577294; Bigaut K, Mallaret M, Baloglu S, Nemoz B, Morand P, Baicry F, et al. Guillain-Barré syndrome related to SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7:e785. Doi:10.1212/NXI.0000000000000785; Gutierrez-Ortiz C, Mendez A, Rodrigo-Rey S, San Pedro-Murillo E, Bermejo-Guerrero L, Gordo-Manas R, et al. Miller Fisher Syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):e601-e605. Doi:10.1212/WNL.0000000000009619; Velayos Galán A, Del Saz Saucedo P, Peinado Postigo F, Botia Paniagua E. Guillain-Barré syndrome associated with SARS-CoV-2 infection. Neurologia. 2020;35(4):268-9. Doi:10.1016/j.nrl.2020.04.007; Lantos JE, Strauss SB, Lin E. COVID-19-Associated Miller Fisher Syndrome: MRI Findings. Am J Neuroradiol. 2020;(7):1184-6. Doi:10.3174/ajnr.A6609; Ameer N, Shekhda KM, Cheesman A. Guillain-Barré syndrome presenting with COVID-19 infection. BMJ Case Rep. 2020;13:e236978. Doi:10.1136/bcr-2020-236978; Bracaglia M, Naldi I, Govoni A, Brillanti Ventura D, De Massis P. Acute infammatory demyelinating polyneuritis in association with an asymptomatic infection by SARS‑CoV‑2. Journal of Neurology. 2020;267:3166-8. Doi:10.1007/s00415-020-10014-2; Zhao H, Shen D, Zhou H, Liu J, Sheng S. Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020;19:383-4.; Oguz-Akarsu E, Ozpar R, Mirzayev H, Acet-Ozturk NA, Hekyemez B, Ediger D, et al. Guillain-Barré Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection. 2020. [Epub ahead of print]. Doi:10.1002/mus.26992; Chan JL, Ebadi H, Sarna JR. Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection. Canadian J Neurolog Scienc. 2020;29:1-3. Doi:10.1017/cjn.2020.106; Ray A. Miller Fisher syndrome and COVID-19: is there a link? BMJ Case Rep. 2020;13:e236419. Doi:10.1136/bcr-2020-236419; Scheidl E, Diez-Canseco D, Hadji-Naumov A, Bereznai B. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature. J Peripher Nerv Syst. 2020;25(2):204-7. Doi:10.1111/jns.12382; Kilinc D, van de Pasch S, Doets AY, Jacobs BC, van Vliet J, Garssen MPJ. Guillain-Barré syndrome after SARS-CoV-2 infection. Eur J Neurol. 2020;27(9):1757-8. Doi:10.1111/ene.14398; Padroni M, Mastrangelo V, Asioli GM, Pavolucci L, Abu-Rumeileh S, Piscaglia MG, et al. Guillain‑Barré syndrome following COVID‑19: new infection, old complication? J Neurol 2020;267(7):1877-9. Doi:10.1007/s00415-020-09849-6; Riva N, Russo T, Falzone YM, Strollo M, Amadio S, Del Carro U, et al. Post‑infectious Guillain–Barré syndrome related to SARS‑CoV‑2 infection: a case report. J Neurol, 2020;267:2492-4. Doi:10.1007/s00415-020-09907-z; Helbok R, Beer R, Loscher W, Boesch S, Reindl M, Hornung R, et al. Guillain-Barré syndrome in a patient with antibodies against SARS-COV-2. European journal of neurology. 2020;27(9):1754-6. Doi: https://doi.org/10.1111/ene.14388; Reyes-Bueno JA, Garcia-Trujillo L, Urbaneja P, Ciano-Petersen NL, Postigo-Pozo MJ, Martinez-Tomas C, et al. Miller-Fisher syndrome after SARS-CoV-2 infection. Eur J Neurol. 2020;27:1759-61. Doi:10.1111/ENE.14383; Fernandez Dominguez J, Ameijide Sanluis E, Garcia Cabo C, Garcia Rodriguez R, Mateos V. MillerFisher‑like syndrome related to SARS‑CoV‑2 infection (COVID 19). J Neurology. 2020;267(9):2495-6. Doi:10.1007/s00415-020-09912-2; Naddaf E, Laughlin RS, Klein CJ, Toledano M, Theel ES, Binnicker MJ, et al. Guillain-Barré Syndrome in a Patient with Evidence of Recent SARS-CoV-2 Infection. Mayo Clin Proc. 2020;95(8):1799-801. Doi:10.1016/j.mayocp.2020.05.029.; Senel M, Abu-Rumeileh S, Michel D, Garibashvili T, Althaus K, Kassubek J, et al. Miller-Fisher syndrome after COVID-19: neurochemical markers as an early sign of nervous system involvement. Eur J Neurol. 2020 Nov;27(11):2378-80. Doi:10.1111/ene.14473.; Hirayama T, Hongo Y, Kaida K, Kano O. Guillain-Barré syndrome after COVID-19 in Japan. BMJ Case Rep. 2020 Oct 29;13(10):e239218. doi:10.1136/bcr-2020-239218.; Marta-Enguita J, Rubio-Baines I, Gastón-Zubimendi I. Fatal Guillain-Barre syndrome after infection with SARS-CoV-2. Neurologia. 2020;35(4):265-7. Doi:10.1016/j.nrl.2020.04.004; Manganotti P, Pesavento V, Buoite Stella A, Bonzi L, Campagnolo E, Bellavista G, et al. Miller Fisher syndrome diagnosis and treatment in a patient with SARS-CoV-2. J Neurovirol. 2020;26:605-6. Doi:10.1007/s13365-020-00858-9; Su XW, Palka SV, Rao RR, Chen FS, Brackney CR, Cambi F. SARS-CoV-2–associated Guillain-Barré syndrome with dysautonomia. Muscle & Nerve. 2020;62(2):E48-E49. Doi:10.1002/mus.26988; Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, et al. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. 2020;41(6):1351-4. Doi:10.1007/s10072-020-04449-8; Wada S, Nagasaki Y, Arimizu Y, Shimo M, Matsukuma Y, Okamoto M, et al. Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection. Intern Med. 2020;59:2187-9. Doi:10.2169/internalmedicine.5447-20; Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M. New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurological Science. 2020;41:1657-8. Doi:10.1007/s10072-020-04484-5; Rana S, Lima AA, Chandra R, Valeriano J, Desai T, Freiberg W, et al. Novel Coronavirus (COVID-19)-Associated Guillain–Barre syndrome: case report. J Clin Neuromusc Dis. 2020;21:240-2.; Lascano AM, Epiney JB, Coen M, Serratrice J, Bernard-Valnet R, Lalive PH, et al. SARS-CoV-2 and Guillain-Barré syndrome: AIDP variant with favorable outcome. Eur J Neurol. 2020;27(9):1751-3. Doi: https://10.1111/ENE.14369; Candessanche JP, Morel J, Pozzetto B, Paul S. COVID-19 may induce Guillain-Barre´ syndrome. Rev Neurolog. 2020;176:516-25. Doi:10.1016/j.neurol.2020.04.003; Webb S, Wallace VCJ, Martin-Lopez D, Yogarajah M. Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complication. BMJ Case Rep. 2020;13:e236182. Doi:10.1136/bcr-2020-236182; Virani A, Rabold E, Hanson T, Haag A, Elrufay R, Cheema T, et al. Guillain-Barré Syndrome associated with SARS-CoV-2 infection. ID Cases. 2020;20:e00771. Doi: https://10.1016/j.idcr.2020.e00771; Diez-Porras L, Verges E, Gil F, Vidal MJ, Massons J, Arboix A. Guillain-Barré-Strohl syndrome and COVID-19: Case report and literature review. Neuromuscular Disorders. 2020;30(10):859-61. Doi:10.1016/j.nmd.2020.08.354; El Otmani H, El Moutawaki B, Rafai MA, El Benna N, El Kettani C, Soussi M, et al. Covid-19 and Guillain-Barre´ syndrome: More than a coincidence! Rev Neurolog. 2020;176:516-25. Doi:10.1016/j.neurol.2020.04.007; Ghiasvand F, Ghadimi M, Ghadimi F, Safarpour S, Hosseinzadeh R, Seyed Alinaghi SA. Symmetrical polyneuropathy in coronavirus disease 2019 (COVID-19). IDCases. 2020;20:e00815. Doi:10.1016/j.idcr.2020.e00815; Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, et al. Guillain-Barre syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7:e741. Doi:10.1212/NXI.0000000000000741; Berlin DA, Gulick RM, Martinez FJ. Severe Covid-19. N Engl J Med. 2020;383:2451-60. Doi:10.1056/NEJMcp2009575; Levison LS, Thomsen RW, Christensen DH, Mellmjaer T, Sindrup SH, Andersen H. Guillain-Barré syndrome in Denmark: validation of diagnostic codes and a population-based nationwide study of the incidence in a 30-year period. Clin Epidemiol. 2019;11:275-83.; Zhang Y, Zhao Y, Wang Y. Prognostic factors of Guillain-Barré syndrome: a 111-case retrospective review. Chin Neurosurg J. 2018;4:14. Doi:10.1186/s41016-018-0122-y.; Mateen FJ, Cornblath DR, Jafari H, Shinohara RT, Khandit D, Ahuja B, et al. Guillain–Barré Syndrome in India: Population-based validation of the Brighton criteria. Vaccine. 2011;29(52):9697-01. Doi:10.1016/j.vaccine.2011.09.123.; Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, et al. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866-77. Doi:10.1093/brain/awy232.; Gómez Á, Díaz A, Carrión-Penagos J, Reyes J, Reyes S. Clinical and electrophysiological characteristics of Guillain-Barré syndrome in Colombia. J Peripher Nerv Syst. 2019;24(3):268-71. Doi:10.1111/jns.12340.; Vucic S, Cairns KD, Black KR, Tick Chong PS, Cros D. Neurophysiologic findings in early acute inflammatory demyelinating polyradiculoneuropathy. Clinical Neurophysiology. 2004;115(10):2329-35.; Ma YM, Liu TK, Wong V. Guillain-Barre syndrome in southern Chinese children: 32 year experience in Hong Kong. Pediatr Int. 2010;52(1):13-9.; van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10(8):469-82.; Yadegari S, Nafissi S, Kazemi N. Comparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome. Iran J Neurol. 2014;13(3):138-43.; Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain J Neurol. 2014;137:33-43.; Raphael JC, Chevret S, Hughes RA, Annane D. Plasma exchange for Guillain-Barre syndrome. Cochrane Database Syst Rev. 2012;(7):CD001798. Doi:10.1002/14651858.CD001798.pub2; Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2014(9):CD002063. Doi:10.1002/14651858.CD002063.pub6; Hughes RA, Swan AV, Raphaël JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain. 2007;130:2245-57. doi:10.1093/brain/awm004.; van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013 Apr 30;80(18):1650-4. doi:10.1212/WNL.0b013e3182904fcc; Taylor CJ, Hirsch NP, Kullmann DM, Howard RS. Changes in the severity and subtype of Guillain-Barre´ syndrome admitted to a specialist Neuromedical ICU over a 25-year period. J Neurol. 2017;264:564-9. Doi:10.1007/s00415-016-8380-0; Akbayram S, Dogan M, Akgun C, Peker E, Sayiotan R, Aktar F, et al. Clinical features and prognosis with Guillain-Barre syndrome. Ann Indian Acad Neurol. 2011;14(2):98-102. Doi:10.4103/0972-2327.82793.; https://revneuro.sld.cu/index.php/neu/article/view/446

  11. 11
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Report
  15. 15
    Academic Journal
  16. 16
    Dissertation/ Thesis
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
    Academic Journal
  20. 20